Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W McKenzie

Showing results (11-20 of 101) with videos related to

Pageof 11
Sort By:
The British Journal of Dermatology|May 1, 1972
The oral contraceptive and variegate porphyriaA W McKenzie, U Acharya
The British Journal of Dermatology|May 1, 1975
A new formulation of 0.1% hydrocortisone cream with vasoconstrictor activity and clinical effectivenessM Whitefield, A W McKenzie
Clinical Pharmacy|May 1, 1983
Digoxin pharmacokinetics and dosage requirements in pediatric patientsR Bendayan, M W McKenzie
Science (New York, N.Y.)|August 22, 1975
Leukocyte recruitment to airways by cigarette smoke and particle phase in contrast to cytotoxicity of vaporK H Kilburn, W McKenzie
The British Journal of Dermatology|October 1, 1981
An unusual presentation of systemic amyloidosisG Fairrie, A W McKenzie
Scientific Reports|July 25, 2020
Genetic interaction between central pair apparatus genes CFAP221, CFAP54, and SPEF2 in mouse models of primary ciliary dyskinesiaCasey W McKenzie, Lance Lee
The American Journal of the Medical Sciences|July 14, 2019
Blood Cultures and Culture ChangeStacey W McKenzie, Robert T Means
Drug Intelligence & Clinical Pharmacy|November 1, 1984
Pharmacists' views on mandatory patient counselingJ D Robinson, M W McKenzie
The British Journal of Dermatology|October 1, 1978
Bullous pemphigoid and primary biliary cirrhosisD V Hamilton, A W McKenzie
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 1, 1997
Extreme hyperferritinemia in patients infected with human immunodeficiency virus is not a highly specific marker for disseminated histoplasmosisS W McKenzie, R T Means
Pageof 11

Showing results (11-20 of 101) with videos related to

Sort By:
Pageof 11
The British Journal of Dermatology|May 1, 1972
The oral contraceptive and variegate porphyriaA W McKenzie, U Acharya
The British Journal of Dermatology|May 1, 1975
A new formulation of 0.1% hydrocortisone cream with vasoconstrictor activity and clinical effectivenessM Whitefield, A W McKenzie
Clinical Pharmacy|May 1, 1983
Digoxin pharmacokinetics and dosage requirements in pediatric patientsR Bendayan, M W McKenzie
Science (New York, N.Y.)|August 22, 1975
Leukocyte recruitment to airways by cigarette smoke and particle phase in contrast to cytotoxicity of vaporK H Kilburn, W McKenzie
The British Journal of Dermatology|October 1, 1981
An unusual presentation of systemic amyloidosisG Fairrie, A W McKenzie
Scientific Reports|July 25, 2020
Genetic interaction between central pair apparatus genes CFAP221, CFAP54, and SPEF2 in mouse models of primary ciliary dyskinesiaCasey W McKenzie, Lance Lee
The American Journal of the Medical Sciences|July 14, 2019
Blood Cultures and Culture ChangeStacey W McKenzie, Robert T Means
Drug Intelligence & Clinical Pharmacy|November 1, 1984
Pharmacists' views on mandatory patient counselingJ D Robinson, M W McKenzie
The British Journal of Dermatology|October 1, 1978
Bullous pemphigoid and primary biliary cirrhosisD V Hamilton, A W McKenzie
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 1, 1997
Extreme hyperferritinemia in patients infected with human immunodeficiency virus is not a highly specific marker for disseminated histoplasmosisS W McKenzie, R T Means
Pageof 11